11 Exenatide has been associated with hypoglycemia when given in combination with metformin, SUs, and TZDs
Results vary, and medication works best with nutrition guidance and consistent follow-up care
The SELECT mediation analysis tells us that at least two-thirds of the MACE protection comes from something other than adiposity reduction
When administered, semaglutide activates GLP-1 receptors, leading to several beneficial effects: Insulin Release: It stimulates the pancreas to release more insulin when blood sugar levels are high, helping to lower glucose
Retatrutide, with its triple-receptor action, could outperform both Tirzepatide and Semaglutide for some patients, but more data is needed
Macrolide antibiotics like azithromycin may increase the likelihood of nausea or abdominal discomfort when combined with semaglutide due to overlapping GI side effects